Vertex Pharmaceuticals VRTX Goodwill
Goodwill at other companies
Other financials
Where this comes from
Reported directly by Vertex Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The official record: Vertex Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vertex Pharmaceuticals's goodwill.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vertex Pharmaceuticals's goodwill?
- Vertex Pharmaceuticals (VRTX) reported goodwill of $1.09B in Q1 2026.
- How has Vertex Pharmaceuticals's goodwill changed year-over-year?
- Vertex Pharmaceuticals's goodwill decreased by 0.0% year-over-year, from $1.09B to $1.09B.
- What is the long-term trend for Vertex Pharmaceuticals's goodwill?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's goodwill has grown at a 1.7% compound annual growth rate (CAGR), from $1B to $1.09B.
- What does goodwill mean?
- The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.